Biotech Values

[north40000]

GSK/Agenus malaria vaccine is news as well

Also Gates funded, announced 2 days ago:

http://www.businessweek.com/news/2011-10-18/glaxo-vaccine-reduces-malaria-in-african-children-by-half.html

http://www.forbes.com/sites/matthewherper/2011/10/18/glaxosmithkline-bill-gates-backed-vaccine-cuts-malaria-infections-by-half/

http://www.reuters.com/article/2011/10/18/us-malaria-vaccine-gsk-idUSTRE79H58T20111018

......shares in GSK's small U.S. biotech partner Agenus, which makes a component of the vaccine, rose more than 40 percent after news of the clinical trial result.....

It seems there are a number of players in this field.